| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10219340 | The Journal of Urology | 2018 | 23 Pages |
Abstract
PI-RADS version 2 is significantly associated with the presence of clinically significant prostate cancer. The cancer detection rate of PI-RADS version 2 category 4 lesions was considerably higher than previously reported. When performing targeted biopsy, the combination with systematic biopsy still provides the highest detection of clinically significant prostate cancer.
Keywords
PI-RADS™ISUPCDRmpMRIMultiparametric MRIPCAMRIInternational Society of Urological PathologyImage-guided biopsysystematic biopsyTargeted biopsyDiagnosisMagnetic resonance imagingRadiographic image interpretationNeoplasm gradingProstate cancerUltrasoundTransitional zoneperipheral zonecancer detection rateProstatic neoplasmscomputer-assistedProstate Imaging Reporting and Data System
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Sebastian L. Hofbauer, Andreas Maxeiner, Beatrice Kittner, Robin Heckmann, Maximillian Reimann, Laura Wiemer, Patrick Asbach, Matthias Haas, Tobias Penzkofer, Carsten Stephan, Frank Friedersdorff, Florian Fuller, Kurt Miller, Hannes Cash,